SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
CSTL

Castle Biosciences Inc (NASDAQ:CSTL)

US · Delayed Price · Currency is USD
Healthcare · Medical - Diagnostics & Research
$32.86-$0.55 (-1.63%)
 
Market cap
$1.01B
Insider Score
Health Score
Analyst consensus
Listed since
Jul 25, 2019
Market Cap$1.01B-14.6%
Revenue (ttm)$377.13M+9.8%
Net Income-$23.01M-88.1%
EPS-$0.77-72.1%
Shares Out30.82M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume309,216
Open$33.02
Previous Close$33.41
Day's Range$32.54 - $33.37
52-Week Range$17.72 - $44.28
Beta0.95
AnalystsBuy
Price Target$38.75(+17.92%)
Earnings DateFeb 25, 2027

About CSTL

Castle Biosciences, Inc. functions as a commercial-stage diagnostics firm, with its primary objective being the provision of both diagnostic and prognostic testing services, specifically targeting various dermatological cancers. Their flagship product, DecisionDx-Melanoma, represents an advanced multi-gene expression profile (GEP) assay engineered to assess the probability of metastasis in patients afflicted with invasive cutaneous melanoma. In addition to their leading solution, the company has created several other specialized, proprietary tests. Among these is DecisionDx-UM, a GEP test tailored to forecast the risk of metastasis for individuals with uveal melanoma, a less common malignancy of the eye. Another key offering is DecisionDx-SCC, a distinctive 40-gene expression profile test that utilizes a patient's unique tumor biology to predict their specific risk of squamous cell carcinoma metastasis, particularly for those presenting with recognized risk factors. Moreover, they offer DecisionDx DiffDx-Melanoma and myPath Melanoma, both proprietary GEP tests employed to assist in the accurate diagnosis of ambiguous pigmented lesions. These specialized testing services are provided by Castle Biosciences to patients predominantly through their healthcare providers. The organization commenced operations in 2007 and maintains its corporate headquarters in Friendswood, Texas.

Address
1500 W. Parkwood Ave, Friendswood, TX, 77546, US
Market Cap
1.01 billion
Employees
1,002
Industrial Classification
Medical - Diagnostics & Research

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$2.61M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
3 Buy0 Hold0 SellAvg target $45.25 (+37.7%)

3 firms rating CSTL in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Sound
From CSTL’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-1.63%
5 Days
-1.68%
1 Month
-0.99%
6 Months
+63.08%
1 Year
-14.63%

$CSTL stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.

→ All Stock Lists

Congress Trading

Recent trades of CSTL by members of U.S. Congress

Josh GottheimerHouse / DSale$1.00K – $15.00KMar 15, 2022
Gilbert Ray CisnerosHouse / DPurchase$1.00K – $15.00KDec 23, 2020
Gilbert CisnerosHouse / DPurchase$1.00K – $15.00KDec 23, 2020
Gilbert Ray CisnerosHouse / DPurchase$1.00K – $15.00KDec 22, 2020
Josh GottheimerHouse / DPurchase$1.00K – $15.00KDec 21, 2020

Recently reported changes in CSTL holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by CSTL's directors and management

Net Shares Purchased by Insiders−80k−40k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

CSTL Estimated quarterly lobbying spending

Source: U.S. Senate LDA

CSTL Revenue by Segment

$102.89MTotal
Non-Dermatologic$55.01M53.47%
Dermatologic$47.88M46.53%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New CSTL patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to CSTL from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in CSTL

IWMiShares Russell 2000 ETF$26.32M
VTIVanguard Morningstar Total Stock Market ETF$25.38M
VXFVanguard Extended Market ETF$12.92M
IWNiShares Russell 2000 Value ETF$9.46M
FESMFidelity Enhanced Small Cap ETF$7.92M
IBBiShares Biotechnology ETF$7.81M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from CSTL’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
99
News & Sentiment
20% of score
72

News check: Raised 2026 guidance and revenue growth drive bullish sentiment; positive clinical data and analyst optimism support upside potential.

Recent Insider Activity

Buys
0
Sells
23
Buy Value
$0
Distinct Buyers
0

Insider Score Trend Over Time

-35.0 since Aug 21
0255075100Aug 21 — Insider Score 35.0Aug 22 — Insider Score 36.0Aug 23 — Insider Score 36.0Aug 24 — Insider Score 36.0Aug 25 — Insider Score 36.0Aug 26 — Insider Score 36.0Aug 27 — Insider Score 36.0Aug 28 — Insider Score 36.0Aug 29 — Insider Score 36.0Aug 30 — Insider Score 36.0Aug 31 — Insider Score 36.0Sep 1 — Insider Score 0.0Sep 2 — Insider Score 0.0Sep 3 — Insider Score 0.0Sep 4 — Insider Score 0.0Sep 5 — Insider Score 0.0Sep 6 — Insider Score 0.0Sep 7 — Insider Score 0.0Sep 8 — Insider Score 0.0Sep 9 — Insider Score 0.0Sep 10 — Insider Score 0.0Sep 11 — Insider Score 0.0Sep 12 — Insider Score 0.0Sep 13 — Insider Score 0.0Sep 14 — Insider Score 0.0Sep 15 — Insider Score 0.0Sep 16 — Insider Score 0.0Sep 17 — Insider Score 0.0Sep 18 — Insider Score 0.0Sep 19 — Insider Score 0.0Sep 20 — Insider Score 0.0Sep 21 — Insider Score 0.0Sep 22 — Insider Score 0.0Sep 23 — Insider Score 0.0Sep 24 — Insider Score 0.0Sep 25 — Insider Score 0.0Sep 26 — Insider Score 0.0Sep 27 — Insider Score 0.0Sep 28 — Insider Score 0.0Sep 29 — Insider Score 0.0Sep 30 — Insider Score 0.0Oct 1 — Insider Score 0.0Oct 2 — Insider Score 31.0Oct 3 — Insider Score 0.0Oct 4 — Insider Score 0.0Aug 21Sep 12Oct 4

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

XHSState Street SPDR S&P Health Care Services ETF1.26%
GNMXCorgi ETF Trust I - Corgi Genomics & Precision Medicine ETF0.81%
NSCSNuveen Small Cap Select0.73%
SVALiShares US Small Cap Value Factor ETF0.54%
HAPSHarbor Human Capital Factor US Small Cap ETF0.54%
LITLSimplify Piper Sandler US Small-Cap PLUS Income ETF0.48%
ETHOAmplify Etho Climate Leadership U.S. ETF0.41%
FSEVFidelity Enhanced Small Cap Value ETF0.26%
IWCiShares Micro-Cap ETF0.25%
ISMDInspire Small/Mid Cap ETF0.19%
BSVOEA Bridgeway Omni Small-Cap Value ETF0.18%
IHFiShares U.S. Healthcare Providers ETF0.13%

Weight is the stock’s share of each fund’s holdings.